產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
DU 145 (人前列腺癌細胞) (STR鑒定正確)
貨號：CL-0075
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價格： ￥1400
生長培養(yǎng)基：MEM（含NEAA）＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | DU 145 (人前列腺癌細胞) (STR鑒定正確) |
| 別稱 | DU-145; Du-145; DU 145; DU_145; Duke University 145 |
| 種屬 | 人 |
| 生長特性 | 貼壁細胞 |
| 細胞形態(tài) | 上皮細胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認） |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:3-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | DU 145細胞是從一位有3年淋巴細胞白血病史的前列腺癌患者的腦部轉(zhuǎn)移病灶損害中建株的。DU 145細胞和從軟瓊脂中分離到的細胞不具有可檢測的激素敏感性，酸性磷酸酶呈弱陽性。對DU 145細胞及原始腫瘤細胞的亞顯微結(jié)構(gòu)分析可見微絨毛，微絲及細胞橋粒，有許多線粒體，發(fā)育良好高爾基體和異質(zhì)溶酶體。DU 145細胞不表達前列腺抗體。 |
| 年齡（性別） | 男性；69歲 |
| 組織來源 | 前列腺；轉(zhuǎn)移灶；腦癌 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 前列腺癌細胞 |
| 生物安全等級 | BSL-1 |
| 倍增時間 | ~30-40 hours |
| 致瘤性 | Yes, in nude mice; forms adenocarcinoma (grade II) consistent with prostatic primary. |
| 抗原表達情況 | Blood Type O; Rh+ |
| 保藏機構(gòu) | ATCC; HTB-81 BCRC; 60348 BCRJ; 0078 DSMZ; ACC-261 |
STR鑒定
-
STR位點信息
Amelogenin X,Y CSF1PO 10,11 D2S1338 16,17 D3S1358 16 D5S818 10,13 D7S820 7,10,11 D8S1179 13,14 D13S317 12,14 D16S539 11,13 D18S51 12 D19S433 13 D21S11 30,33 FGA 21,22 PentaD 9,13 PentaE 12,14 TH01 7 TPOX 11 vWA 17,18,19 D6S1043 11 D12S391 17,18,20,21 D2S441 9,14 -
STR鑒定圖
-
參考文獻
-
Non-destructive in situ monitoring of structural changes of 3D tumor spheroids during the formation, migration, and fusion process (2025-02-12)
期刊：eLife
影響因子 ：6.4
引用產(chǎn)品： DU 145 細胞 , NK-92 細胞 , NK-92細胞專用培養(yǎng)基
-
Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1 (2025-01-16)
期刊：MOLECULAR MEDICINE
DOI：10.1186/s10020-025-01073-0
影響因子 ：6.0
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞
-
Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer (2024-03-21)
期刊：CELL DEATH AND DIFFERENTIATION
DOI：10.1038/s41418-024-01282-w
影響因子 ：12.4
-
METTL3-mediated m6A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy (2024-08-14)
期刊：CELLULAR & MOLECULAR BIOLOGY LETTERS
DOI：10.1186/s11658-024-00628-z
影響因子 ：9.2
-
Environmental explanation of prostate cancer progression based on the comprehensive analysis of polychlorinated biphenyls (2024-07-18)
期刊：SCIENCE OF THE TOTAL ENVIRONMENT
DOI：10.1016/j.scitotenv.2024.174870
影響因子 ：8.2
引用產(chǎn)品： PC-3細胞專用培養(yǎng)基 , PC-3 細胞 , DU 145細胞專用培養(yǎng)基 , DU 145 細胞
-
Metabolic characterization of sphere-derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance (2024-04-22)
期刊：INTERNATIONAL JOURNAL OF CANCER
影響因子 ：6.4
-
Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1–SNAI1 axis (2024-07-18)
期刊：JOURNAL OF PATHOLOGY
影響因子 ：5.6
引用產(chǎn)品： DU 145 細胞 , PC-3M-2B4 細胞
-
Cytotoxic and Antibacterial Meroterpenoids Isolated from the Marine-Derived Fungus Talaromyces sp. M27416 (2024-04-20)
期刊：Marine Drugs
影響因子 ：5.4
引用產(chǎn)品： K-562 [K562] 細胞 , TE-1 細胞 , HOS 細胞 , GBC-SD 細胞 , PaTu 8988t 細胞 , DU 145 細胞 , 293T [HEK-293T] 細胞 , SF126 細胞 , MCF7 [MCF-7] 細胞 , HCT 116 細胞 , Hela 細胞 , A549 [A-549] 細胞 , Hep G2 細胞 , A-375 細胞 , MKN-45 細胞 , 5637 細胞 , 786-O [786-0] 細胞 , CAL-62 細胞 , A-673 細胞 , HL-7702 [L-02; LO2] 細胞
-
Wound healing assay on a gravity-driven unidirectional perfusion microfluidic device (2024-11-27)
期刊：MICROCHEMICAL JOURNAL
DOI：10.1016/j.microc.2024.112289
影響因子 ：4.9
引用產(chǎn)品： DU 145 細胞
-
YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation (2024-03-09)
期刊：JOURNAL OF BIOLOGICAL CHEMISTRY
影響因子 ：4.8
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , 22RV1 細胞 , Ham's F-12K 培養(yǎng)基 , MEM (含NEAA) 培養(yǎng)基 , RPMI-1640 培養(yǎng)基
-
Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics (2024-04-19)
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：4.8
引用產(chǎn)品： LNCaP clone FGC 細胞 , 22RV1 細胞 , PC-3 細胞 , DU 145 細胞
-
Identification of neutrophil extracellular traps (NETs)-related molecular clusters in prostate cancer: Implications for predicting biochemical recurrence (2024-12-28)
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2024.113908
影響因子 ：4.8
-
Characterizing adipocytokine-related signatures for prognosis prediction in prostate cancer (2024-10-25)
期刊：Frontiers in Cell and Developmental Biology
DOI：10.3389/fcell.2024.1475980
影響因子 ：4.6
-
Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer (2024-04-26)
期刊：Scientific Reports
DOI：10.1038/s41598-024-57303-8
影響因子 ：4.6
引用產(chǎn)品： RWPE-1 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , PC-3 細胞
-
Natural flavonoid glycoside-based self-assembled nanoparticles for synergistic antibacterial activity and improved antioxidant properties (2024-12-30)
期刊：JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
DOI：10.1016/j.jddst.2024.106583
影響因子 ：4.5
引用產(chǎn)品： DU 145 細胞
-
Meta-biosensor with High Q-factor Based on Wet Etching for Terahertz Detection (2024-02-27)
期刊：IEEE SENSORS JOURNAL
影響因子 ：4.3
-
The Mechanism by Which Hedgehog Interacting Protein (HHIP) in Cancer-Associated Fibroblasts Regulate the Secretion of Inflammatory Factors Through the JAK1/STAT3 Pathway Affecting Prostate Cancer Stemness (2024-11-11)
期刊：Journal of Inflammation Research
影響因子 ：4.2
引用產(chǎn)品： DU 145 細胞 , DMEM/F12 培養(yǎng)基 , PC-3 細胞
-
A Pump-Free Microfluidic Co-Culture System for Investigating NK Cell-Tumor Spheroid Interactions in Flow Conditions (2024-11-15)
期刊：JOURNAL OF BIOTECHNOLOGY
DOI：10.1016/j.jbiotec.2024.11.008
影響因子 ：4.1
引用產(chǎn)品： NK-92 細胞 , PNT1A 細胞 , NK-92細胞專用培養(yǎng)基 , DU 145 細胞
-
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming (2024-02-24)
期刊：INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
DOI：10.1016/j.biocel.2024.106554
影響因子 ：4.0
引用產(chǎn)品： DU 145 細胞 , PC-3M 細胞 , LNCaP clone FGC 細胞
-
Epigenetic-related Gene-based Prognostic Model Construction and Validation in Prostate Adenocarcinoma (2024-05-08)
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e30941
影響因子 ：4.0
-
Therapeutic targets of formononetin for treating prostate cancer at the single-cell level (2024-06-13)
期刊：Aging-US
影響因子 ：3.9
引用產(chǎn)品： DU 145 細胞
-
The Impact of 3D Tumor Spheroid Maturity on Cell Migration and Invasion Dynamics (2024-11-08)
期刊：BIOCHEMICAL ENGINEERING JOURNAL
影響因子 ：3.7
引用產(chǎn)品： MCF7 [MCF-7] 細胞 , EMT6 [EMT-6] 細胞 , DU 145 細胞
-
PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer (2024-02-21)
期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
DOI：10.1016/j.bbrc.2024.149703
影響因子 ：3.1
-
Self-supply of hydrogen peroxide by a bimetal-based nanocatalytic platform to enhance chemodynamic therapy for tumor treatment (2024-11-08)
期刊：NANOTECHNOLOGY
影響因子 ：2.9
-
Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs (2024-08-08)
期刊：EUROPEAN JOURNAL OF MEDICAL RESEARCH
DOI：10.1186/s40001-024-02000-5
影響因子 ：2.8
引用產(chǎn)品： BPH-1 細胞 , C4-2 細胞 , PC-3 細胞 , RWPE-1 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞
-
CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signaling pathways via up-regulating LAMB3 in prostate cancer (2024-07-22)
期刊：JOURNAL OF BIOCHEMISTRY
影響因子 ：2.1
引用產(chǎn)品： RPMI-1640 培養(yǎng)基 , PC-3 細胞 , 22RV1 細胞 , 青霉素-鏈霉素溶液（雙抗），100× , LNCaP clone FGC 細胞 , DMEM高糖 培養(yǎng)基 , DU 145 細胞 , 特級胎牛血清 , MEM 培養(yǎng)基
-
TMED3 promotes prostate cancer via FOXO1a and FOXO3a phosphorylation (2024-12-20)
期刊：ONCOLOGY RESEARCH
影響因子 ：2.0
引用產(chǎn)品： DU 145 細胞
-
Relationship between circulating miRNA-222-3p and miRNA-136-5p and the efficacy of docetaxel chemotherapy in metastatic castration-resistant prostate cancer patients (2024-12-21)
期刊：BMC Urology
DOI：10.1186/s12894-024-01666-7
影響因子 ：1.7
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , Ham's F-12K 培養(yǎng)基 , MEM（含NEAA） 培養(yǎng)基
-
Circ_0006220 (circ-TADA2A) accelerates prostate cancer cell malignant behaviors through miR-520f-3p/CDCA7 axis (2024-07-28)
期刊：CELLULAR AND MOLECULAR BIOLOGY
影響因子 ：1.5
引用產(chǎn)品： 22RV1 細胞 , RWPE-1 細胞 , DMEM高糖完全培養(yǎng)基（含10% FBS） , SILAC RPMI-1640 培養(yǎng)基 , DU 145 細胞 , VCaP 細胞 , PC-3 細胞 , Ham's F-12完全培養(yǎng)基（含10% FBS）
-
Accurate Visualization of Metabolic Aberrations in Cancer Cells by Temperature Mapping with Quantum Coherence Modulation Microscopy (2023-04-27)
期刊：ACS Nano
影響因子 ：17.1
引用產(chǎn)品： A549 [A-549] 細胞 , Hela 細胞 , Hep G2 細胞 , BxPC-3 細胞 , DU 145 細胞 , 4T1 細胞 , BEAS-2B 細胞 , MET-5A 細胞 , 潮霉素B溶液 (50mg/mL)
-
ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003 (2023-12-04)
期刊：Journal of Translational Medicine
DOI：10.1186/s12967-023-04760-w
影響因子 ：7.4
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , RWPE-1 細胞 , 293T [HEK-293T] 細胞
-
A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients (2023-03-14)
期刊：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 ：5.6
引用產(chǎn)品： RWPE-1 細胞 , 22RV1 細胞 , PC-3 細胞 , DU 145 細胞 , DU 145細胞專用培養(yǎng)基 , PC-3細胞專用培養(yǎng)基
-
Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression (2023-07-15)
期刊：American Journal of Cancer Research
DOI：PMID:37559989
影響因子 ：5.3
-
PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway. (2023-10-27)
期刊：Aging-US
影響因子 ：5.2
引用產(chǎn)品： 青霉素-鏈霉素溶液（雙抗），100× , DU 145 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清 , PC-3 細胞 , RWPE-1 細胞
-
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer (2023-07-25)
期刊：Aging-US
影響因子 ：5.2
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞 , RPMI-1640 培養(yǎng)基
-
Orthogonal Optimization, Characterization, and In Vitro Anticancer Activity Evaluation of a Hydrogen Peroxide-Responsive and Oxygen-Reserving Nanoemulsion for Hypoxic Tumor Photodynamic Therapy (2023-03-03)
期刊：Cancers
影響因子 ：5.2
-
A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance (2023-04-08)
期刊：Scientific Reports
DOI：10.1038/s41598-023-27975-9
影響因子 ：4.6
引用產(chǎn)品： HK-2 細胞 , 786-O [786-0] 細胞 , Caki-1 細胞 , SV-HUC-1 細胞 , T24 [T-24] 細胞 , 5637 細胞 , RWPE-1 細胞 , PC-3 細胞 , DU 145 細胞 , DMEM高糖 培養(yǎng)基 , RPMI-1640 培養(yǎng)基 , Ham's F-12K 培養(yǎng)基 , 人前列腺上皮細胞完全培養(yǎng)基
-
USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma (2023-07-26)
期刊：MOLECULAR CARCINOGENESIS
DOI：10.1002/mc.23609
影響因子 ：4.6
-
YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH (2023-09-29)
期刊：MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI：10.1007/s11010-023-04847-4
影響因子 ：4.3
引用產(chǎn)品： PC-3 細胞 , Ham's F-12K 培養(yǎng)基 , 特級胎牛血清 , DU 145 細胞 , MEM (含NEAA) 培養(yǎng)基
-
Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer (2023-06-10)
期刊：EXPERIMENTAL CELL RESEARCH
DOI：10.1016/j.yexcr.2023.113686
影響因子 ：3.7
引用產(chǎn)品： PC-3 細胞 , LNCaP clone FGC 細胞 , DU 145 細胞 , WPMY-1 細胞
-
A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer (2023-02-24)
期刊：Frontiers in Genetics
DOI：10.3389/fgene.2023.1096783
影響因子 ：3.7
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , RWPE-1 細胞
-
Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing (2023-06-07)
期刊：Diagnostics
DOI：10.3390/diagnostics13121997
影響因子 ：3.6
-
A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes (2023-08-22)
期刊：CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 ：3.4
引用產(chǎn)品： DU 145 細胞 , LNCaP clone FGC 細胞
-
Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis (2023-09-23)
期刊：JOURNAL OF MOLECULAR HISTOLOGY
DOI：10.1007/s10735-023-10156-3
影響因子 ：3.2
引用產(chǎn)品： DU 145 細胞 , PC-3 細胞 , Ham's F-12K 培養(yǎng)基 , MEM (含NEAA) 培養(yǎng)基 , 特級胎牛血清 , 青霉素-鏈霉素溶液 (雙抗)，100×
-
Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer (2023-04-12)
期刊：PeerJ
影響因子 ：2.7
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞
-
Circ_0005276 Promotes Prostate Cancer Progression Through the Crosstalk of miR-128-3p/DEPDC1B Axis (2023-03-13)
期刊：BIOCHEMICAL GENETICS
DOI：10.1007/s10528-022-10328-y
影響因子 ：2.4
引用產(chǎn)品： LNCaP clone FGC 細胞 , DU 145 細胞 , RPMI-1640 培養(yǎng)基 , 特級胎牛血清 , RWPE-1 細胞 , K-SFM 培養(yǎng)基 , EGF/Urogastrone/URG, Human, Recombinant
-
TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α (2023-11-10)
期刊：JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
影響因子 ：2.3
-
Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in?vitro and in?vivo (2023-08-08)
期刊：Oncologie
DOI：10.1515/oncologie-2023-0233
影響因子 ：0.9
-
FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway (2022-08-13)
期刊：Cancers
影響因子 ：6.6
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. (2022-09-21)
期刊：Frontiers in Pharmacology
影響因子 ：6.0
引用產(chǎn)品： SV-HUC-1 細胞 , T24 [T-24] 細胞 , 5637 細胞 , HK-2 細胞 , 786-O [786-0] 細胞 , Caki-1 細胞 , RWPE-1 細胞 , PC-3 細胞 , DU 145 細胞 , Ham's F-12K 培養(yǎng)基 , DMEM高糖 培養(yǎng)基 , 人前列腺上皮細胞完全培養(yǎng)基 , RPMI-1640 培養(yǎng)基
-
Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway (2022-11-11)
期刊：Translational Oncology
DOI：10.1016/j.tranon.2022.101578
影響因子 ：4.8
-
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer (2022-10-25)
期刊：PeerJ
影響因子 ：3.1
引用產(chǎn)品： PC-3 細胞 , DU 145 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞
-
Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer (2022-01-07)
期刊：Biochemical Genetics
DOI：10.1007/s10528-021-10160-w
影響因子 ：2.4
引用產(chǎn)品： DU 145 細胞 , LNCaP clone FGC 細胞 , DMEM高糖完全培養(yǎng)基 (含10%FBS) , RPMI-1640完全培養(yǎng)基 (含10%FBS) , RWPE-1 細胞
-
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway (2021-08-19)
期刊：Journal Of Cellular And Molecular Medicine
影響因子 ：5.3
引用產(chǎn)品： C4-2 細胞 , PC-3 細胞 , 22RV1 細胞 , LNCaP clone FGC 細胞 , DU 145 細胞
-
MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways (2021-11-10)
期刊：Journal Of Cellular And Molecular Medicine
影響因子 ：5.3
引用產(chǎn)品： DU 145 細胞 , PC-3 細胞 , LNCaP clone FGC 細胞 , 22RV1 細胞
-
Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src (2021-10-28)
期刊：Endocrine
DOI：10.1007/s12020-021-02907-7
影響因子 ：3.9
-
Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy (2021-11-19)
期刊：Andrologia
影響因子 ：2.4
引用產(chǎn)品： LNCaP clone FGC 細胞 , PC-3 細胞 , DU 145 細胞 , RPMI-1640 培養(yǎng)基 , Ham's F-12K 培養(yǎng)基 , MEM (含NEAA) 培養(yǎng)基 , 特級胎牛血清 , 青霉素-鏈霉素溶液 (雙抗)，100× , RWPE-1 細胞 , RWPE-1細胞專用培養(yǎng)基
-
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration?resistant prostate cancer (2020-11-19)
期刊：Oncology Letters
影響因子 ：2.9
-
Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models (2020-12-15)
期刊：Bioscience Biotechnology and Biochemistry
影響因子 ：1.6
-
Silencing of MALAT1 inhibits migration and invasion by sponging miR?1?3p in prostate cancer cells (2019-08-22)
期刊：Molecular Medicine Reports
影響因子 ：3.4
引用產(chǎn)品： 293T [HEK-293T] 細胞 , DU 145 細胞 , DU 145細胞專用培養(yǎng)基 , PC-3 細胞 , PC-3細胞專用培養(yǎng)基
-
Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells (2019-01-07)
期刊：Pathology Research And Practice
影響因子 ：2.8
引用產(chǎn)品： DU 145 細胞 , MEM (含NEAA) 培養(yǎng)基 , PC-3 細胞 , Ham's F-12K 培養(yǎng)基
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
